Holen Sie sich die Stockscreener-App
0.30
74.79%
-0.89
Handel nachbörslich:
.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ORGS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.19
Offen:
$0.575
24-Stunden-Volumen:
725
Relative Volume:
8.59
Marktkapitalisierung:
$N/A
Einnahmen:
$662.00K
Nettoeinkommen (Verlust:
$-29.02M
KGV:
-0.0353
EPS:
-8.5
Netto-Cashflow:
$-12.54M
1W Leistung:
-74.79%
1M Leistung:
-74.79%
6M Leistung:
-74.79%
1J Leistung:
-86.10%
1-Tages-Spanne:
$0.30
$0.575
1-Wochen-Bereich:
$0.30
$0.575
52-Wochen-Spanne:
$0.30
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
Compare ORGS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.30 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-12-20 | Eingeleitet | Dawson James | Buy |
Orgenesis Inc Aktie (ORGS) Neueste Nachrichten
Patience Required for Orgenesis Investors as Strategic Model Takes Shape - AD HOC NEWS
The Truth About Orgenesis Inc (ORGS): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS
Orgenesis (NASDAQ:ORGS) Trading Up 300% – Here’s What Happened - Defense World
GLP-1 Receptor Agonist Market to Witness Massive Growth by 2033 | Perrigo Company PLC, 3M Company, Bausch Health - Weekly Voice
Orgenesis Issues Alpha Warrant in New Financing Deal - TipRanks
Orgenesis issues warrant for 3.29 million shares tied to $1 million loan - Investing.com
Orgenesis Signs Warrant Issuance Agreement With Alpha Prosperity Fund - TradingView
The Truth About Orgenesis (ORGS): Tiny Biotech, Massive Hype – But Should You Touch It? - AD HOC NEWS
Is Orgenesis Inc. (45O) stock a safe buy pre earnings2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда
Retail Trends: Is Orgenesis Inc 45O stock a safe buy pre earnings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - moha.gov.vn
Aug Gainers: Is Orgenesis Inc 45O stock a safe buy pre earningsInflation Watch & Verified Swing Trading Watchlists - moha.gov.vn
Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant
Published on: 2025-12-23 22:10:30 - earlytimes.in
Regenerative Therapies Market Forecast Through 2032 - openPR.com
Statera Biopharma (NASDAQ:STAB) vs. Orgenesis (NASDAQ:ORGS) Financial Contrast - Defense World
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer - Business Wire
Is Oriental Culture Holding LTD a good long term investmentUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
Financial Contrast: Pharmaxis (OTCMKTS:PXSLY) and Orgenesis (NASDAQ:ORGS) - Defense World
What analysts say about GoPro Inc stockResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
How Orgenesis Inc. (45O) stock trades in high volatility2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Is Orgenesis Inc. (45O) stock suitable for passive index fundsWeekly Gains Report & Precise Swing Trade Alerts - Newser
Apex Tech Acquisition Inc files for IPO of up to $60 million - marketscreener.com
Is Orgenesis Inc. (45O) stock protected from inflation2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
How Orgenesis Inc. (45O) stock compares with top peersShort Setup & Accurate Entry/Exit Alerts - Newser
Why Orgenesis Inc. (45O) stock attracts HNW investorsJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
Onconase (Ranpirnase) | Benefits and Side Effects - Mesothelioma.net
Will Orgenesis Inc. (45O) stock beat international competition2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Orgenesis (NASDAQ:ORGS) Stock Price Up 257.1% – Here’s Why - Defense World
Will Orgenesis Inc. (45O) stock gain from lower interest ratesProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Orgenesis Inc. (45O) stock a buy during volatile marketsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Why Orgenesis Inc. (45O) stock is a strong analyst pick2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsMarket Growth Report & Community Verified Trade Alerts - newser.com
Finanzdaten der Orgenesis Inc-Aktie (ORGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.45%
Kapitalisierung:
|
Volumen (24h):